International Journal of Indian Medicine

ISSN: 0000-0000

Year: 2025 |Volume: 6 | Issue: 11


A Clinical Case Report on Management of Acute Episodes of Tamakashwasa in Pediatric Patient

About Author

Shwetha D.1 , Vijayalaxmi M.2 , Annapurna P.3

1HOD & Prof, Dept of Kaumarabhritya, at Tapovana Ayurvedic Medical college and Hospital, Doddabatti, Davanagere, PhD Scholar at SDMC&H Hassan

2HOD & Professor Dept of Kaumarabhritya, at Sri Dharmasthala Manjunatheshwara college of ayurveda & Hospital, Hassan.

3Associate prof, Dept of kaumarabhritya, at shri hingulambika ayurved medical college and hospital, kalaburagi, PhD scholar at SDMCA&H Hassan.


Date of Acceptance: 2025-11-13

Date of Publication:2025-12-06

Correspondence Address:

Dr. Shwetha D. HOD & Prof, Dept of Kaumarabhritya, at Tapovana Ayurvedic Medical college and Hospital, Doddabatti, Davanagere, PhD Scholar at SDMC&H Hassan Email- shwethad7@gmail.com , Mobile no: - 9844938263
Article-ID:IJIM_465_12_25 https://ijim.co.in

Keywords: Spirometry, Nebulization, Shati Arka, Vital capacity


Source of Support: Nil

Conflict of Interest: Non declared


Abstract


Introduction: Bronchial asthma is a long-standing inflammatory condition of the airways that leads to repeated episodes of airflow obstruction. Diagnosis is based on clinical symptoms along with pulmonary function tests, with Spirometry and Peak Expiratory Flow Rate (PEFR) being the main assessments. Ayurveda considers the equivalent disease of the bronchial asthma is Tamaka Shwasa. the present clinical trail is planned to evaluate the effect of Shati Arka nebulization in acute episodes of Tamaka Shwasa in children. Case Presentation: A 11-year-old male from Davanagere presented to the Kaumarbhritya outpatient department at Tapovana Ayurveda Medical College and Hospital-Doddabathi.He reported experiencing cough and cold lasting 4–6 days, along with breathlessness persisting over the past two and half years. The diagnosis was made based on the clinical signs and symptoms along with the Global Initiative for Asthma (GINA) criteria for bronchial asthma. Trial drug Shati Arka was administered through nebulization with the dose of 3.5ml of Arka every 6th hourly for the duration of 3 days. Result: The PEFR reading had very good improvement from 170 to 190 L/Min. And the spirometric measurement (FEV1/FVC)changes from 86.8 % to 91 %. Discussion: Nebulization with Shati helps liquefy and expel phlegm from the respiratory passages, clear the Pranavaha Srotas, and improve airflow during asthma episodes. Conclusion: The findings of this study support the efficacy of Shati Arka in enhancing lung function and restoring vital capacity.